tiprankstipranks

RadNet initiated with a Buy at B. Riley

B. Riley initiated coverage of RadNet (RDNT) with a Buy rating and $69 price target The company is the largest operator of outpatient radio imaging centers, the analyst tells investors in a research note. The firm says RadNet “is one of a kind of publicly traded companies” in the radiopharma value chain, which has a U.S.-centric operation that is relatively immune to tariffs. The company is a “one-stop shop,” offering both advanced imaging and routine imaging, contends Riley. It believes RadNet benefits from favorable industry trends of shifting imaging procedures from hospitals to non-hospital imaging centers and emerging novel radio imaging agents.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1